Literature DB >> 32461320

Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes.

Mahesh Chemudupati1,2, Adam D Kenney1,2, Anna C Smith1,3,2, Robert J Fillinger1,2,4, Lizhi Zhang1,2, Ashley Zani1,2, Shan-Lu Liu1,3,2,4, Matthew Z Anderson1,2,4, Amit Sharma1,3,2, Jacob S Yount5,2,4.   

Abstract

Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequately investigated. We found that butyrate increases cellular infection with viruses relevant to human and animal health, including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus. Mechanistically, butyrate suppresses levels of specific antiviral IFN-stimulated gene (ISG) products, such as RIG-I and IFITM3, in human and mouse cells without inhibiting IFN-induced phosphorylation or nuclear translocation of the STAT1 and STAT2 transcription factors. Accordingly, we discovered that although butyrate globally increases baseline expression of more than 800 cellular genes, it strongly represses IFN-induced expression of 60% of ISGs and upregulates 3% of ISGs. Our findings reveal that there are differences in the IFN responsiveness of major subsets of ISGs depending on the presence of butyrate in the cell environment, and overall, they identify a new mechanism by which butyrate influences virus infection of cells.IMPORTANCE Butyrate is a lipid produced by intestinal bacteria. Here, we newly show that butyrate reprograms the innate antiviral immune response mediated by type I interferons (IFNs). Many of the antiviral genes induced by type I IFNs are repressed in the presence of butyrate, resulting in increased virus infection and replication. Our research demonstrates that metabolites produced by the gut microbiome, such as butyrate, can have complex effects on cellular physiology, including dampening of an inflammatory innate immune pathway resulting in a proviral cellular environment. Our work further suggests that butyrate could be broadly used as a tool to increase growth of virus stocks for research and for the generation of vaccines.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  ISG; interferon

Mesh:

Substances:

Year:  2020        PMID: 32461320      PMCID: PMC7394905          DOI: 10.1128/JVI.00326-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  90 in total

Review 1.  Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responses.

Authors:  Joe F Lau; Curt M Horvath
Journal:  Mt Sinai J Med       Date:  2002-05

Review 2.  Gut microbiota, metabolites and host immunity.

Authors:  Michelle G Rooks; Wendy S Garrett
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

3.  Sodium Butyrate Protects -Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice.

Authors:  Ling Zhang; Jianfeng Du; Naohiro Yano; Hao Wang; Yu Tina Zhao; Patrycja M Dubielecka; Shougang Zhuang; Y Eugene Chin; Gangjian Qin; Ting C Zhao
Journal:  J Cell Biochem       Date:  2017-04-25       Impact factor: 4.429

4.  IFITM3 protects the heart during influenza virus infection.

Authors:  Adam D Kenney; Temet M McMichael; Alexander Imas; Nicholas M Chesarino; Lizhi Zhang; Lisa E Dorn; Qian Wu; Omar Alfaour; Foued Amari; Min Chen; Ashley Zani; Mahesh Chemudupati; Federica Accornero; Vincenzo Coppola; Murugesan V S Rajaram; Jacob S Yount
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

5.  Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils.

Authors:  Marco A R Vinolo; Hosana G Rodrigues; Elaine Hatanaka; Fábio T Sato; Sandra C Sampaio; Rui Curi
Journal:  J Nutr Biochem       Date:  2010-12-16       Impact factor: 6.048

6.  Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.

Authors:  Alexander Vogt; Margaret A Scull; Tamar Friling; Joshua A Horwitz; Bridget M Donovan; Marcus Dorner; Gisa Gerold; Rachael N Labitt; Charles M Rice; Alexander Ploss
Journal:  Virology       Date:  2013-06-16       Impact factor: 3.616

7.  HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells.

Authors:  James Arthos; Claudia Cicala; Elena Martinelli; Katilyn Macleod; Donald Van Ryk; Danlan Wei; Zhen Xiao; Timothy D Veenstra; Thomas P Conrad; Richard A Lempicki; Sherry McLaughlin; Massimiliano Pascuccio; Ravindra Gopaul; Jonathan McNally; Catherine C Cruz; Nina Censoplano; Eva Chung; Kristin N Reitano; Shyam Kottilil; Diana J Goode; Anthony S Fauci
Journal:  Nat Immunol       Date:  2008-02-10       Impact factor: 25.606

8.  Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT.

Authors:  Bastiaan W Haak; Eric R Littmann; Jean-Luc Chaubard; Amanda J Pickard; Emily Fontana; Fatima Adhi; Yangtsho Gyaltshen; Lilan Ling; Sejal M Morjaria; Jonathan U Peled; Marcel R van den Brink; Alexander I Geyer; Justin R Cross; Eric G Pamer; Ying Taur
Journal:  Blood       Date:  2018-04-19       Impact factor: 25.476

9.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

10.  Maternal treatment with short-chain fatty acids modulates the intestinal microbiota and immunity and ameliorates type 1 diabetes in the offspring.

Authors:  James C Needell; Diana Ir; Charles E Robertson; Miranda E Kroehl; Daniel N Frank; Danny Zipris
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

View more
  21 in total

Review 1.  Innate immune sensing by epithelial barriers.

Authors:  David A Constant; Timothy J Nice; Isabella Rauch
Journal:  Curr Opin Immunol       Date:  2021-08-13       Impact factor: 7.486

Review 2.  Congenital Infection Influence on Early Brain Development Through the Gut-Brain Axis.

Authors:  Gregory W Kirschen; Snigdha Panda; Irina Burd
Journal:  Front Neurosci       Date:  2022-06-30       Impact factor: 5.152

3.  Gut Microbiota of Obese Children Influences Inflammatory Mucosal Immune Pathways in the Respiratory Tract to Influenza Virus Infection: Optimization of an Ideal Duration of Microbial Colonization in a Gnotobiotic Pig Model.

Authors:  Sankar Renu; Loic Deblais; Veerupaxagouda Patil; Jennifer Schrock; Dipak Kathayat; Vishal Srivastava; Ninoshkaly Feliciano-Ruiz; Yi Han; Anikethana Ramesh; Yashavanth S Lakshmanappa; Shristi Ghimire; Santosh Dhakal; Gireesh Rajashekara; Gourapura J Renukaradhya
Journal:  Microbiol Spectr       Date:  2022-05-17

Review 4.  Microbiota-immune system interactions and enteric virus infection.

Authors:  Mikal A Woods Acevedo; Julie K Pfeiffer
Journal:  Curr Opin Virol       Date:  2020-09-06       Impact factor: 7.090

Review 5.  Intestinal Microbiota-A Promising Target for Antiviral Therapy?

Authors:  Mengling Yang; Yang Yang; Qingnan He; Ping Zhu; Mengqi Liu; Jiahao Xu; Mingyi Zhao
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 6.  Polymicrobial Interactions Operative during Pathogen Transmission.

Authors:  Hannah M Rowe; Jason W Rosch
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

7.  The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.

Authors:  Johanna Reinold; Farnoush Farahpour; Ann-Kathrin Schoerding; Christian Fehring; Sebastian Dolff; Margarethe Konik; Johannes Korth; Lukas van Baal; Jan Buer; Oliver Witzke; Astrid M Westendorf; Jan Kehrmann
Journal:  Front Cell Infect Microbiol       Date:  2022-04-19       Impact factor: 6.073

8.  Microbiota-derived short-chain fatty acids do not interfere with SARS-CoV-2 infection of human colonic samples.

Authors:  Lívia Bitencourt Pascoal; Patrícia Brito Rodrigues; Lívia Moreira Genaro; Arilson Bernardo Dos Santos Pereira Gomes; Daniel Augusto Toledo-Teixeira; Pierina Lorencini Parise; Karina Bispo-Dos-Santos; Camila Lopes Simeoni; Paula Veri Guimarães; Lucas Ildefonso Buscaratti; João Gabriel De Angeli Elston; Henrique Marques-Souza; Daniel Martins-de-Souza; Maria De Lourdes Setsuko Ayrizono; Lício Augusto Velloso; José Luiz Proenca-Modena; Pedro Manoel Mendes Moraes-Vieira; Marcelo Alves Silva Mori; Alessandro Santos Farias; Marco Aurélio Ramirez Vinolo; Raquel Franco Leal
Journal:  Gut Microbes       Date:  2021 Jan-Dec

9.  Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19.

Authors:  Yamilé López-Hernández; Joel Monárrez-Espino; Ana-Sofía Herrera-van Oostdam; Julio Enrique Castañeda Delgado; Lun Zhang; Jiamin Zheng; Juan José Oropeza Valdez; Rupasri Mandal; Fátima de Lourdes Ochoa González; Juan Carlos Borrego Moreno; Flor M Trejo-Medinilla; Jesús Adrián López; José Antonio Enciso Moreno; David S Wishart
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

Review 10.  The influence of microbiota-derived metabolites on viral infections.

Authors:  Ajisha Alwin; Stephanie M Karst
Journal:  Curr Opin Virol       Date:  2021-06-16       Impact factor: 7.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.